Post by BioDuro

💡 ADCs continue to push drug discovery into increasingly complex territory, bringing both new opportunities and higher scientific and technical demands. In a recent BioPharm International virtual panel discussion, our CSO Dr. Subas M Sakya, highlights that these programs require more specialized approaches in design, synthesis, and analytical strategies. He also emphasizes the importance of deep integration across chemistry, biology, drug metabolism and pharmacokinetics, and bioanalysis to support successful development. Read the full article — a useful perspective on how the field is evolving alongside ADC innovation. https://lnkd.in/gZBSriGc #ADCs #DrugDiscovery #Biopharma